AI News
Marketers say NAD+ pills and infusions can boost longevity. What’s the evidence?
Navigating the hype surrounding NAD+ supplementation and the lack of clinical evidence for human longevity.
Read the full story at Google News AIGNA
Google News AI
Source
Google News AI
AI Analysis
Generated insight by OnAirToday AI
The trend toward longevity-focused biohacking highlights a growing gap between aggressive marketing claims and clinical proof. As interest in NAD+ grows, consumers remain vulnerable to unverified health promises that currently lack robust long-term human data.
Powered by AI • Not a substitute for human analysisMore Insights →
Share
Filed under:AI News
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.